CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2024
May 6 02:36 ET
CLOVER BIO-B: Form of Proxy for Use at Annual General Meeting
Apr 25 07:46 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE PRELIMINARY PHASE I RESULTS FOR BIVALENT RSV VACCINE CANDIDATE SCB-1019 IN INITIAL YOUNG ADULT COHORT
Apr 8 05:02 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2024
Apr 3 05:14 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 29, 2024
Mar 4 02:12 ET
CLOVER BIO-B: Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
Feb 22 03:36 ET
CLOVER BIO-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
Feb 22 03:35 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2024
Feb 1 21:51 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2023
Jan 2 22:03 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER ANNOUNCES POSITIVE PHASE I RESULTS FOR SCB-219M FOR TREATMENT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT)
Dec 28, 2023 18:00 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER INITIATES PHASE I CLINICAL TRIAL FOR RSV VACCINE CANDIDATE
Dec 12, 2023 18:31 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2023
Dec 5, 2023 01:29 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER COMPLETES BLA SUBMISSION FOR SEASONAL INFLUENZA VACCINE IN BRAZIL
Nov 6, 2023 18:45 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2023
Nov 2, 2023 05:56 ET
CLOVER BIO-B: (Revised)Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2023
Nov 2, 2023 05:55 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2023
Oct 8, 2023 20:01 ET
CLOVER BIO-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
Sep 15, 2023 04:38 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER LAUNCHES QUADRIVALENT SEASONAL INFLUENZA VACCINE IN MAINLAND CHINA
Sep 11, 2023 19:45 ET
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended August 31, 2023
Sep 4, 2023 23:45 ET
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT INTENTION OF DIRECTOR TO INCREASE SHAREHOLDING IN THE COMPANY
Aug 22, 2023 20:01 ET
No Data
No Data